enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.890
+0.020 (1.07%)
At close: Sep 15, 2026, 4:00 PM EDT
1.890
0.00 (0.00%)
After-hours: Sep 15, 2026, 4:37 PM EDT
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $126.66 million as of September 15, 2026. Its market cap has decreased by -56.67% in one year.
Market Cap
126.66M
Enterprise Value
-106.39M
1-Year Change
-56.67%
Ranking
Category
Stock Price
$1.89
ChartMarket Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $126.66M, a decrease of -18.76%. That is a compound annual growth rate of -4.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 126.66M | -79.06% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Conexeu Sciences | 133.79M |
| Milestone Pharmaceuticals | 133.78M |
| Equillium | 132.84M |
| TuHURA Biosciences | 130.64M |
| Biomea Fusion | 129.02M |
| Cellectis | 126.27M |
| Inovio Pharmaceuticals | 122.01M |
| OnKure Therapeutics | 121.49M |